logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11110097 B1

PDFFull Text
Date of Patent:
Sep. 07, 2021

Filed:

Sep. 13, 2019

Combination therapies for the treatment of alzheimer's disease and related disorders

Applicant:

The General Hospital Corporation, Boston, MA (US);

Inventor:

David R. Elmaleh, Newton, MA (US);

Assignee:

The General Hospital Corporation, Boston, MA (US);

Attorneys:

Foley Hoag LLP

Janine S. Ladislaw

Lawrence P. Tardibono

Primary Examiner:

Shirley V Gembeh

Int. Cl.
CPC ...
A61K 31/5415 (2006.01); A61K 45/06 (2006.01); A61K 31/192 (2006.01); A61K 31/352 (2006.01); A61K 31/428 (2006.01); A61K 31/438 (2006.01); A61K 31/706 (2006.01); A61K 31/047 (2006.01); A61K 31/225 (2006.01); A61K 31/435 (2006.01); A61K 51/04 (2006.01); A61K 31/13 (2006.01); A61K 31/194 (2006.01); A61K 31/075 (2006.01); A61K 31/55 (2006.01); A61K 31/713 (2006.01); A61K 38/18 (2006.01); A61K 39/00 (2006.01); C07K 16/18 (2006.01); A61K 31/353 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5415 (2013.01); A61K 31/047 (2013.01); A61K 31/075 (2013.01); A61K 31/13 (2013.01); A61K 31/192 (2013.01); A61K 31/194 (2013.01); A61K 31/225 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/428 (2013.01); A61K 31/435 (2013.01); A61K 31/438 (2013.01); A61K 31/55 (2013.01); A61K 31/706 (2013.01); A61K 31/713 (2013.01); A61K 38/185 (2013.01); A61K 39/0005 (2013.01); A61K 45/06 (2013.01); A61K 51/0453 (2013.01); C07K 16/18 (2013.01); A61K 48/00 (2013.01);
Abstract

The present invention relates to combination therapies for treating Alzheimer's disease or an amyloidosis-associated pathological condition comprising co-administering a therapeutically effective amount of a first compound, and a therapeutically effective amount of a second compound. In certain embodiments, the first compound or the second compound inhibits AB peptide polymerization; is an anti-inflammatory; improves cognitive function, mood, or social behavior; is associated with Tau or alpha-synuclein; or regulates amyloid peptide washout.

Find Patent Forward Citations

Elmaleh, David. (2021). Combination therapies for the treatment of alzheimer's disease and related disorders (U.S. Patent No. 11110097). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11110097

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…